10X Genomics Inc vs Veeva Systems — how do they compare? 10X Genomics Inc trades at $67.8 (market cap $8.55B), while Veeva Systems trades at $260.88 (market cap $42.88B). The key difference: Veeva Systems is far larger — about 5× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Veeva Systems nearer its low. Which is the better fit depends on your goals.
| TXG | VEEV | |
|---|---|---|
Market Cap | $8.55B | $42.88B |
Sector | Health | Technology |
52-Week High | $67.29 | $306.22 |
52-Week Low | $11.34 | $151.43 |
Enterprise Value | $8.08B | $35.79B |
Signals from Pluang's Aura AI — not financial advice
TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.
The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →